These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2868651

  • 1. Thyrotropin-receptor autoantibodies in children and young adults with Graves' disease.
    Brown RS, Kertiles LP, Rosenfield C, Kleinmann RE, Crigler JF.
    Am J Dis Child; 1986 Mar; 140(3):238-41. PubMed ID: 2868651
    [Abstract] [Full Text] [Related]

  • 2. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y, Hamazu M, Kajita Y, Nagata A.
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
    Cho BY, Shong MH, Yi KH, Lee HK, Koh CS, Min HK.
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
    [Abstract] [Full Text] [Related]

  • 5. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 6. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 7. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.
    Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N.
    Endocr J; 2005 Oct; 52(5):505-10. PubMed ID: 16284425
    [Abstract] [Full Text] [Related]

  • 8. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J, Hamada N, Saito H, Oyanagi H, Ishikawa N, Momotani N, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY, Shong YK, Lee HK, Koh CS, Min HK.
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [Abstract] [Full Text] [Related]

  • 11. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 12. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
    Iitaka M, Tanikawa T, Sakatsume Y, Yanagisawa M, Hara Y, Ishii J.
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
    [Abstract] [Full Text] [Related]

  • 13. Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease.
    de Bruin TW, van der Heide D, Querido A, Krol MC.
    Clin Endocrinol (Oxf); 1984 Feb; 20(2):143-51. PubMed ID: 6325045
    [Abstract] [Full Text] [Related]

  • 14. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC, Hay ID, Nelson RE, Jiang NS.
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.
    Akamizu T, Mori T, Imura H, Noh J, Hamada N, Ito K, Koizumi Y, Yamada T, Fujihira T, Eto S.
    J Endocrinol Invest; 1989 Jul; 12(7):483-8. PubMed ID: 2571629
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
    Bliddal H, Bech K, Siersbaek-Nielsen K, Friis T.
    J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
    [Abstract] [Full Text] [Related]

  • 18. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease (author's transl)].
    Endo K.
    Nihon Naibunpi Gakkai Zasshi; 1979 Oct 20; 55(10):1261-74. PubMed ID: 228998
    [Abstract] [Full Text] [Related]

  • 19. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H, Amino N, Watanabe Y, Aozasa M, Hayashi H, Tachi J, Miyai K.
    J Clin Lab Immunol; 1986 May 20; 20(1):1-6. PubMed ID: 3016274
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.